Dr. Jaideep Malhotra, founder of Rainbow IVF moderated the discussion. Panel speakers included Dr. Neena Malhotra, AIIMS Professor and Secretary General, Indian Fertility Society, Dr. Kaberi Banerjee, Medical Director, Advanced Fertility and Gynecologist Center, and Dr. S Prakash Subbarayan, Managing Director, Star Health and Allied Insurance Co ltd.
Dr. J Malhotra started the discussion by stating that “it is very important for us to understand that infertility is not an easy thing, either to treat or not to treat, and also that human relationships that revolve around her and society play a huge role. As a result, it could be extremely stressful, isolating and, above all, financially draining.”
To which Doctor Dr N Malhotra, added, “There are two or three reasons why the insurance is not getting in place. Firstly, there is no registry in the country at present, but that does not mean that the country registry has been launched to give an assurance, there is no law on our side of the world, it will take time to roll out.
Dr Banerjee also mentioned that the cost of IVF is a major factor in couples’ decisions, she said: “When patients first come to my practice, the first question they ask is to know what the success rate is and the cages involved.”
From the perspective of insurance companies, Dr Subbarayan said: “There are two things that insurance companies look at: the incidence of the disease and whether they cover a hundred women of childbearing age. , how many will be subject to infertility evaluation. The second is what will be the average cost of the assessment or treatment like IUI and IVI etc. »
He also said: “Insurance companies, especially health insurance companies in India, 90% of them are not making profit as incidence of diseases is increasing and payment to hospital is not regulated.”
“ART Act is really a silver lining for the patient and providers who practice ethical practices and greater traction for the insurance company,” said Dr. N Malhotra.
Dr Banerjee also added saying: “Before deciding which center to go to, cost parameters are the most important thing in IVF, as treatment is not successful at every attempt and providers are under enormous pressure to deliver. quickly and efficiently The subject of insurance is a very broad subject and this will help both patients and providers.
Dr. Subbarayan also commented on what should be covered by insurance and for how long: “Currently health insurance companies are not making a profit. This is number one, number two is that if infertility is to be covered, insurance companies fall under the purview of the Insurance Regulatory Development Authority of India (IRDA) and it makes it clear that even mental health should be considered a disease like any other physical ailment. , so naturally, infertility must be covered. Infertility should be covered by insurance, but it can’t happen all at once. This should be done in a phased manner by looking at common areas of treatment. The main areas of investigation should be covered first. It should be done in a sustainable way.
Dr. J Malhotra, concluded the discussion on “Insurance Growth Prospects in IVF: Impact on Payers, Providers and Patients” by saying, “The message here for the public that they should consider a full coverage, and not just for the public but also for the insurance company. It should start early, like when you get married or when you have polycystic disease, even for the younger age group. If you have full coverage from the start, especially for the group of people who need early ART treatment, this will be possible, and it also helps insurance companies to stay afloat.”